| scholarly article | Q13442814 |
| P2093 | author name string | Richard P Phipps | |
| Majed A Refaai | |||
| Neil Blumberg | |||
| Sherry L Spinelli | |||
| P2860 | cites work | CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells | Q24310570 |
| A randomized trial of washed red blood cell and platelet transfusions in adult acute leukemia [ISRCTN76536440] | Q24801336 | ||
| Release of biologically active CD154 during collection and storage of platelet concentrates prepared for transfusion | Q28221912 | ||
| TRALI: from diagnosis to prevention | Q28250822 | ||
| Dose of prophylactic platelet transfusions and prevention of hemorrhage | Q30496886 | ||
| Transfusion of ABO-mismatched platelets leads to early platelet refractoriness | Q68534410 | ||
| The role of ABO matching in platelet transfusion | Q70578075 | ||
| Platelet-derived microparticles associate with fibrin during thrombosis | Q71099905 | ||
| High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles | Q71735203 | ||
| Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus | Q71781373 | ||
| A possible survival advantage in adults with acute leukemia receiving ABO-identical platelet transfusions | Q72323530 | ||
| Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000/microL versus 20,000/microL | Q73132195 | ||
| Shear-induced platelet activation and platelet microparticle formation at blood flow conditions as in arteries with a severe stenosis | Q73236217 | ||
| Plasma and lipids from stored platelets cause acute lung injury in an animal model | Q73288183 | ||
| Effect of filtration and storage of platelet concentrates on the production of the chemotaxins C5a, interleukin 8, tumor necrosis factor alpha, and leukotriene B4 | Q74242637 | ||
| A prospective randomized trial of prophylactic platelet transfusion and bleeding incidence in hematopoietic stem cell transplant recipients: 10,000/L versus 20,000/microL trigger | Q78523412 | ||
| The causes and treatment of reactions to platelet transfusions | Q78859791 | ||
| An association of soluble CD40 ligand (CD154) with adverse reactions to platelet transfusions | Q79142074 | ||
| Cooperation between platelet-derived CD154 and CD4+ T cells for enhanced germinal center formation | Q81757066 | ||
| Human platelets can activate peripheral blood B cells and increase production of immunoglobulins. | Q33291901 | ||
| Clinical consequences of alterations in platelet transfusion dose: a prospective, randomized, double-blind trial | Q33329515 | ||
| Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology | Q33336231 | ||
| Platelet washing to prevent recurrent febrile reactions to leucocyte-reduced transfusions | Q33337118 | ||
| Prophylactic platelet transfusions from healthy apheresis platelet donors undergoing treatment with thrombopoietin | Q33338652 | ||
| Guidelines for the use of platelet transfusions | Q33348675 | ||
| Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients | Q33364823 | ||
| Platelets express functional Toll-like receptor-4. | Q33366814 | ||
| The effects of platelet transfusions evaluated using rotational thromboelastometry | Q33384125 | ||
| Thrombocytopenia: mechanisms and management of defects in platelet production | Q33454890 | ||
| Reliability of automated platelet counts: comparison with manual method and utility for prediction of clinical bleeding | Q33489457 | ||
| The role of the plasma from platelet concentrates in transfusion reactions | Q33491828 | ||
| The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. | Q33501152 | ||
| Safety and cost effectiveness of a 10 x 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia | Q33502337 | ||
| Platelet transfusion: a dose-response study. | Q33503245 | ||
| Current concepts in platelet transfusion | Q33560053 | ||
| The platelet as an immune cell-CD40 ligand and transfusion immunomodulation | Q33937074 | ||
| An association between decreased cardiopulmonary complications (transfusion-related acute lung injury and transfusion-associated circulatory overload) and implementation of universal leukoreduction of blood transfusions | Q34148215 | ||
| The platelet CD40L/GP IIb-IIIa axis in atherothrombotic disease | Q35197406 | ||
| Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury | Q35849153 | ||
| Transfusion-related acute lung injury and the ICU. | Q36181638 | ||
| Soluble CD40 ligand induces β 3 integrin tyrosine phosphorylation and triggers platelet activation by outside-in signaling | Q36350146 | ||
| Platelet-derived CD154 enables T-cell priming and protection against Listeria monocytogenes challenge | Q36508925 | ||
| Soluble CD40 ligand induces endothelial dysfunction in human and porcine coronary artery endothelial cells | Q36941078 | ||
| Modulation of monocyte-endothelial cell interactions by platelet microparticles | Q37387105 | ||
| TRALI--definition, mechanisms, incidence and clinical relevance | Q37399178 | ||
| Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer | Q37416199 | ||
| Platelets expressing P-selectin and platelet-derived microparticles in stored platelet concentrates bind to PSGL-1 on filtrated leukocytes | Q40613596 | ||
| A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusions | Q40712333 | ||
| Limited efficacy of leukopoor platelets for prevention of febrile transfusion reactions | Q40748675 | ||
| Algorithm for managing the platelet refractory patient | Q41428082 | ||
| Platelet derived CD154 (CD40 ligand) and febrile responses to transfusion | Q43662394 | ||
| Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes | Q44903709 | ||
| Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes | Q45092053 | ||
| Platelet transfusion and survival in adults with acute leukemia | Q45240552 | ||
| The CD40-TRAF6 axis is the key regulator of the CD40/CD40L system in neointima formation and arterial remodeling | Q47245105 | ||
| Preventing platelet-derived microparticle formation--and possible side effects-with prestorage leukofiltration of whole blood. | Q50578775 | ||
| Activated platelets induce tissue factor expression on human umbilical vein endothelial cells by ligation of CD40 | Q62604578 | ||
| Supernatant of stored platelets causes lung inflammation and coagulopathy in a novel in vivo transfusion model | Q62977607 | ||
| Use of leukocyte-depleted platelet concentrates for the prevention of refractoriness and primary HLA alloimmunization: a prospective, randomized trial | Q68177018 | ||
| P433 | issue | 4 | |
| P921 | main subject | inflammation | Q101991 |
| thrombosis | Q261327 | ||
| P304 | page(s) | 287-291 | |
| P577 | publication date | 2010-11-19 | |
| P1433 | published in | Thrombosis Research | Q15758741 |
| P1476 | title | Platelet transfusions: impact on hemostasis, thrombosis, inflammation and clinical outcomes | |
| P478 | volume | 127 |
| Q33618448 | A computerized prediction model of hazardous inflammatory platelet transfusion outcomes |
| Q35622496 | Antigenic challenge in the etiology of autoimmune disease in women |
| Q28083403 | Are Platelets Cells? And if Yes, are They Immune Cells? |
| Q90392210 | Assessment of soluble platelet CD40L and CD62P during the preparation process and the storage of apheresis platelet concentrates: Absence of factors related to donors and donations |
| Q57801960 | Biomarker Profiling of Neurovascular Diseases in Patients with Stage 5 Chronic Kidney Disease |
| Q40251118 | Blood transfusion and inflammation |
| Q37978627 | Challenges and controversies in the medical management of primary and antithrombotic-related intracerebral hemorrhage |
| Q46248984 | Comprehensive metabolomic study of platelets reveals the expression of discrete metabolic phenotypes during storage. |
| Q88010231 | Determination of predictors of severity for recipient adverse reactions during platelet product transfusions |
| Q43051741 | Do manual and automated processes with distinct additive solutions affect whole blood-derived platelet components differently? |
| Q33432591 | Fibrinogen concentrate improves clot strength in patients with haematological malignancies requiring platelet transfusion |
| Q38145557 | Gateway to understanding microparticles: standardized isolation and identification of plasma membrane-derived vesicles |
| Q26773233 | Hemostasis in liver transplantation: Pathophysiology, monitoring, and treatment |
| Q45832206 | Immune-reactive soluble OX40 ligand, soluble CD40 ligand, and interleukin-27 are simultaneously oversecreted in platelet components associated with acute transfusion reactions. |
| Q26775408 | Improving platelet transfusion safety: biomedical and technical considerations |
| Q38177385 | Incidence of acute transfusion reactions to platelets in hospitalized pediatric patients based on the US hemovigilance reporting system |
| Q49443114 | Leucocyte cytokines dominate platelet cytokines overtime in non-leucoreduced platelet components |
| Q64075133 | Mean platelet volume/platelet count ratio in colorectal cancer: a retrospective clinical study |
| Q91971794 | Platelet Inflammatory Response to Stress |
| Q90373833 | Platelet Transfusion Practice and Related Outcomes in Pediatric Extracorporeal Membrane Oxygenation |
| Q50797044 | Platelet components associated with adverse reactions: predictive value of mitochondrial DNA relative to biological response modifiers. |
| Q33419351 | Platelet transfusion in hematology, oncology and surgery |
| Q34769510 | Platelet-rich plasma promotes the proliferation of human muscle derived progenitor cells and maintains their stemness. |
| Q38017397 | Platelets and cytokines: How and why? |
| Q84760512 | Platelets--to transfuse or not to transfuse |
| Q54968569 | Reactive Oxygen Species Generated by CD45-Cells Distinct from Leukocyte Population in Platelet Concentrates Is Correlated with the Expression and Release of Platelet Activation Markers during Storage. |
| Q53418681 | Removal of biologic response modifiers associated with platelet transfusion reactions: strategies worth considering? |
| Q57024158 | Towards increasing shelf life and haemostatic potency of stored platelet concentrates |
Search more.